Compare ARK Genomic Revolution ETF (ARKG) vs iShares MSCI Singapore ETF (EWS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MSCI Singapore ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while iShares MSCI Singapore ETF trades at $31.71. The key difference: iShares MSCI Singapore ETF is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EWS | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $31.64 |
52-Week Low | $23.09 | $26.24 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EWS, the iShares MSCI Singapore ETF, trades at $31.64, up 0.89% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF offers a 3.97% dividend yield and is concentrated in Singaporean financials, benefiting from the country's economic stability and AI infrastructure growth. Recent news highlights Singapore's push for AI adoption and property market strength.
Outlook: EWS provides diversified exposure to Singapore's robust economy, with near-term catalysts from dividend payments and market reforms. Risks include high concentration in financials and sensitivity to Asian economic conditions. The ETF is approaching its 2007 all-time high, suggesting potential resistance ahead.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MSCI Singapore ETF
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →
